Clinical Trials Logo

Supraspinatus Tear clinical trials

View clinical trials related to Supraspinatus Tear.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05660031 Recruiting - Supraspinatus Tear Clinical Trials

Treatment of the Biceps With Concomitant Supraspinatus Tears

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

NCT ID: NCT05590494 Recruiting - Supraspinatus Tear Clinical Trials

Novel Treatment for Rotator Cuff Tears

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (<50%) of the supraspinatus tendon of the rotator cuff.

NCT ID: NCT04670302 Recruiting - Supraspinatus Tear Clinical Trials

Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation

Start date: October 17, 2019
Phase: N/A
Study type: Interventional

This is a non-randomized clinical trial conducted in a single tertiary hospital which investigates the efficacy of allogeneic adipose-derived mesenchymal stem cells and human amniotic membrane (AAdMSC-HAM) composite for supraspinatus tendon repair augmentation